AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 16 filers reported holding AC IMMUNE SA in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,691,000 | -71.6% | 1,324,935 | -46.8% | 0.19% | -85.8% |
| Q4 2018 | $23,545,000 | +18.1% | 2,491,517 | 0.0% | 1.36% | +43.9% |
| Q3 2018 | $19,932,000 | -10.5% | 2,491,517 | +4.3% | 0.95% | -11.9% |
| Q2 2018 | $22,263,000 | -9.9% | 2,388,700 | 0.0% | 1.08% | -21.2% |
| Q1 2018 | $24,699,000 | -19.2% | 2,388,700 | 0.0% | 1.36% | -11.4% |
| Q4 2017 | $30,575,000 | +13.3% | 2,388,700 | 0.0% | 1.54% | +25.5% |
| Q3 2017 | $26,992,000 | +28.4% | 2,388,700 | 0.0% | 1.23% | +9.1% |
| Q2 2017 | $21,021,000 | -15.1% | 2,388,700 | 0.0% | 1.13% | -30.6% |
| Q1 2017 | $24,747,000 | +20.7% | 2,388,700 | +51.3% | 1.62% | -18.8% |
| Q4 2016 | $20,496,000 | -17.0% | 1,579,031 | +5.3% | 2.00% | -8.6% |
| Q3 2016 | $24,705,000 | – | 1,500,000 | – | 2.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 11,297,911 | $55,925,000 | 5.88% |
| Prosight Management, LP | 1,248,453 | $6,180,000 | 3.43% |
| PA Capital LLC | 76,257 | $377,000 | 0.37% |
| Artal Group S.A. | 1,000,000 | $4,950,000 | 0.20% |
| Temasek Holdings (Private) Ltd | 2,614,095 | $12,940,000 | 0.10% |
| COHEN LAWRENCE B | 13,350 | $66,000 | 0.04% |
| Tekla Capital Management LLC | 171,813 | $850,000 | 0.04% |
| Athanor Capital, LP | 108,540 | $537,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 28,600 | $142,000 | 0.02% |
| APPLETON PARTNERS INC/MA | 11,525 | $57,000 | 0.01% |